首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1532578

精子库市场，按服务类型（精子储存、精液分析、基因咨询）、按捐赠者（已知、匿名、身份披露）、按技术（捐赠者授精、试管受精）、按最终用途（医院、诊所、生育中心） - 预测（2024 - 2032）

Sperm Bank Market, By Service Type (Sperm Storage, Semen Analysis, Genetic Consultation), By Donor (Known, Anonymous, ID Disclosure), By Technique (Donor Insemination, IVF), By End-use (Hospitals, Clinics, Fertility Centers) - Forecast (2024 - 2032)

出版日期: 2024年05月24日 | 出版商:

Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在不孕症盛行率上升的推动下，精子库市场规模在 2024 年至 2032 年期间将呈现 3.8% 的复合年增长率。据世界卫生组织称，大约 17.5% 的成年人，即全世界大约六分之一的人患有不孕症。全球约 10-15% 的夫妇患有不孕症，生育延迟、生活方式改变、环境影响和健康状况等因素导致不孕症的发生。这导致对辅助生殖技术（ART）和生育治疗的需求增加。精子捐赠、保存和遗传咨询等服务利用率的提高正在刺激市场成长。

增强型冷冻保存技术正在彻底改变精子库产业，从而改善精子样本的保存和储存。这些进步包括玻璃化方法的发展，该方法可以最大限度地减少冰晶的形成并减少冷冻过程中的细胞损伤。此外，冷冻保护剂解决方案的创新为精子细胞提供了更好的保护，增强了其解冻后的活力。自动冷冻和解冻系统也变得越来越普遍，以确保一致和最佳的保存条件。这些改进透过维持保存的精子的更高品质和活力，显着提高了辅助生殖技术 (ART) 的成功率。

精子库产业根据服务类型、捐赠者、技术、最终用途和地区进行分类。

到 2032 年，遗传咨询领域将快速增长，因为这项服务对于担心将遗传性疾病遗传给孩子的个人和夫妇至关重要。透过提供全面的基因筛检和咨询，精子库可以帮助客户做出明智的决定并选择具有良好遗传特征的捐赠者。这不仅提高了 ART 手术的安全性和成功率，也满足了生殖健康领域对个人化和精准医疗日益增长的需求。

到 2032 年，诊所部门将快速扩张，因为他们与精子银行合作提供一系列服务，包括精子捐赠、子宫内授精 (IUI)、体外受精 (IVF) 和基因筛检。精子库和生育诊所之间的合作关係确保客户获得从初步咨询到成功受孕的全面护理。诊所利用精子银行在捐赠者招募、筛选和保存方面的专业知识，为患者提供高品质的生育解决方案。全球生育诊所数量不断增加，加上其先进的基础设施和熟练的医疗保健专业人员，有利于市场前景。

在支持性监管框架、ART 程序的高度接受度和先进的医疗基础设施的推动下，欧洲精子库产业将在 2032 年之前稳定成长。英国、丹麦和西班牙等国家处于领先地位，提供最先进的生育服务并吸引来自该地区及其他地区的客户。对研发的高度重视，以及旨在改善 ART 效果和扩大可用治疗范围的大量临床研究和试验，将促进产业成长。

产业生态系统分析
产业影响力
- 成长动力
  - 对辅助生殖技术（ART）的需求不断增加
  - 提高意识和教育倡议
  - 不断增长的教育和职业追求正在推迟生育
- 产业陷阱与挑战
  - 严格的监管环境
  - 与这些服务相关的高成本
成长潜力分析
技术景观
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按服务类型，2021 - 2032 年

主要趋势
精子储存
精液分析
遗传咨询

第 6 章：市场估计与预测：按捐赠者分类，2021 - 2032 年

主要趋势
已知捐赠者
匿名捐赠者
身分揭露捐赠者

第 7 章：市场估计与预测：按技术分类，2021 - 2032 年

主要趋势
捐赠者授精
体外受精

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院和诊所
生育诊所和中心
研究所和实验室
其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

California Cryobank
CryoChoice
CryoGam Colorado
Cryos International
European Sperm Bank
Fairfax Cryobank
Fairfax Cryobank
London Sperm Bank
Manhattan Cryobank
Midwest Sperm Bank
New England Cryogenic Center
NW Cryobank
Seattle Sperm Bank
The Sperm Bank of California
Xytex

简介目录

Product Code: 9633

The Sperm Bank Market size will exhibit 3.8% CAGR during 2024-2032, driven by the rising prevalence of infertility. According to WHO, approximately 17.5% of the adult population, or roughly 1 in 6 individuals worldwide, experience infertility. Infertility affects approximately 10-15% of couples globally, with factors such as delayed parenthood, lifestyle changes, environmental influences, and health conditions contributing to the incidence. This has led to a heightened demand for assisted reproductive technologies (ART) and fertility treatments. Increased utilization of services, including sperm donation, preservation, and genetic consultation is stimulating the market growth.

Enhanced cryopreservation techniques are revolutionizing the sperm bank industry, leading to improved preservation and storage of sperm samples. These advancements include the development of vitrification methods, which minimize ice crystal formation and reduce cellular damage during the freezing process. Additionally, innovations in cryoprotectant solutions are providing better protection for sperm cells, enhancing their viability upon thawing. Automated freezing and thawing systems are also becoming more prevalent, ensuring consistent and optimal preservation conditions. These improvements are significantly increasing the success rates of assisted reproductive technologies (ART) by maintaining higher quality and motility of preserved sperm.

The sperm bank industry is classified based on service type, donor, technique, end-use and region.

The genetic consultation segment will grow rapidly through 2032, as this service is crucial for individuals and couples who are concerned about passing on genetic disorders to their children. By providing comprehensive genetic screening and counseling, sperm banks can help clients make informed decisions and choose donors with favorable genetic profiles. This not only enhances the safety and success rates of ART procedures but also addresses the growing demand for personalized and precision medicine in reproductive health.

Clinics segment will expand at a fast pace through 2032, as they collaborate with sperm banks to offer a range of services, including sperm donation, intrauterine insemination (IUI), in vitro fertilization (IVF), and genetic screening. The partnership between sperm banks and fertility clinics ensures that clients receive comprehensive care, from initial consultation to successful conception. Clinics leverage the expertise of sperm banks in donor recruitment, screening, and preservation to provide high-quality fertility solutions to their patients. The increasing number of fertility clinics worldwide, coupled with their advanced infrastructure and skilled healthcare professionals, is favoring the market outlook.

Europe sperm bank industry will grow at a steady pace through 2032, driven by supportive regulatory frameworks, high acceptance of ART procedures, and advanced healthcare infrastructure. Countries such as the United Kingdom, Denmark, and Spain are at the forefront, offering state-of-the-art fertility services and attracting clients from across the region and beyond. A strong emphasis on R&D, with numerous clinical studies and trials aimed at improving ART outcomes and expanding the range of available treatments, will bolster the industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing demand for assisted reproductive technologies (ART)
  - 3.2.1.2 Rising awareness and education initiatives
  - 3.2.1.3 Growing educational and career pursuits are delaying childbearing
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory landscape
  - 3.2.2.2 High cost associated with these services
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Service Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Sperm storage
5.3 Semen analysis
5.4 Genetic consultation

Chapter 6 Market Estimates and Forecast, By Donor, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Known donor
6.3 Anonymous donor
6.4 ID disclosure donor

Chapter 7 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Donor insemination
7.3 In-vitro fertilization

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinics
8.3 Fertility clinics and centers
8.4 Research institutes and laboratories
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa